Search - tctmd.com

Presenter: Hirotoshi Hariki, Junya Shite, Toshiro Shinke, Hiromasa Ootake, Masayuki Nakagawa, Ryouji Nagoshi, Takumi Inoue, Tsuyoshi Oosue, Amane Kozuki, Masamichi Iwasaki, Yu Taniguchi, Hiroto Kinutani, Akihide Konishi, Ryo Nishio, Noritoshi Hiranuma, Ken-ichi Hirata

January 03, 2012

Presentation TCT 2012

Five-Year Outcomes of Sirolimus-Eluting Stent in Patients with Unprotected Left Main Coronary Arteries: the Milan and New-Tokyo Registry.

Presenter: Kensuke Takagi, Alfonso Ielasi, Joanne Shannon, Azeem Latib, Cosmo Godino, Giedrius Davidavicius, Marco Mussardo, Santo Ferrarello, Mauro Carlino, Matteo Montorfano, Alaide Chieffo, Sunao Nakamura, Antonio Colombo

January 03, 2012

Advertisement

TCT-41. The Impact of Left Main Disease on Long-term Clinical Outcomes Among Patients Treated with the Unrestricted Use of Everolimus-Eluting, Sirolimus-Eluting, and...

SORT OUT IV: Xience Holds Edge Over Cypher for Preventing Stent Thrombosis

SORT OUT IV: El Xience Aguanta el Tirón del Cypher en la Prevención de la Trombosis del Stent

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Stent Thrombosis Surprise: Rates Low, Similar for Endeavor and Cypher at 3 Years

SORT OUT III: Riesgo más alto de trombosis del stent muy tardía con Cypher en comparación con Endeavor

SORT OUT III: Higher Risk of Very Late Stent Thrombosis with Cypher vs. Endeavor

Se Publica el RESET: Eficacia y Seguridad Parecidas con SLE y SLS al cabo de 1 Año

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES

Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES

TCTMD’s Top 10 Most Popular News Stories From 2011

Los 10 Artículos Más Populares de TCTMD de 2011

El Bloqueador de la Angiotensina Preserva la Función Endotelial Mejor que el Antagonista del Calcio

Angiotensin Blocker Preserves Endothelial Function Better Than Calcium Antagonist

Very Late Stent Thrombosis and Late TLR After Sirolimus-Eluting Stent Implantation

Trombosis del Stent muy Tardía y RLD Tardía tras Implantación del Stent Liberador de Sirolimus

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Long-term follow up of sirolimus-eluting stent(SES) implanted in coronary bifurcation lesion: Insight from OCT observations

Five-Year Outcomes of Sirolimus-Eluting Stent in Patients with Unprotected Left Main Coronary Arteries: the Milan and New-Tokyo Registry.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content